NSG BioLabs Fuels Biotech Innovation in Singapore and Southeast Asia Through Partnerships with EnterpriseSG and Merck, Alongside Investments from Celadon Partners and ClavystBio
May 8, 2024
Since 2019, NSG BioLabs has been a leader in co-working lab spaces in Singapore, and has nurtured over 40 biotech companies, of which the startups have achieved nearly US$400 million funding in total alongside significant business milestones NSG BioLabs' partnerships with EnterpriseSG and Merck enable the company to enhance its offerings to residents, with the goal of supporting its residents' innovation and R&D endeavours NSG BioLabs has also secured strategic investment of US$14.